PSA Today Dec 24: Topix down for fifth consecutive day / Pharma updates / Suzuki bucking the weak India motorcycle market – Nikkei +1.04%
Japan Market Comment by Pelham Smithers and Julie BooteNikkei ¥23,830.58 (+¥9.47 / +0.04%); Topix ¥1,728.22 (-¥31.20/ -0.07%); ¥/$109.43
Tags: Santen (4536 JT), Shionogi (4507 JT), GlaxoSmithKline (GSK LN), Eisai (4523 JT), Gilead (GILD US), SoftBank Corp (9434 JT), Naver (035420 KS), Line Corp (3938 JT), Internet Initiative Japan (3774 JT), Sumitomo Corp (8053 JT), Nissan (7201 JT), Nidec (6594 JT), Cybozu (4776 JT), Honda (7267 JT), Suzuki (7269 JT)
Main Points
• Topix down five days in a row
• Suzuki bucking the weak India motorcycle market
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.